Walleye Capital’s Cardlytics CDLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-470
Closed -$17.4K 4327
2024
Q4
$17.4K Sell
470
-1,470
-76% -$56.2K ﹤0.01% 4524
2024
Q3
$62.1K Sell
1,940
-1,980
-51% -$110K ﹤0.01% 4568
2024
Q2
$322K Buy
+3,920
New +$424K ﹤0.01% 3917
2020
Q1
Sell
-180
Closed -$113K 1011
2019
Q4
$113K Buy
+180
New +$88K 0.01% 1327

Other funds holding CDLX

Walleye Capital's CDLX Position: Q1 2026 in Review

Walleye Capital sold out of Cardlytics (CDLX) in Q1 2026, closing a stake of 1,075 shares — an estimated $12.4K sold.

Walleye Capital first reported a position in CDLX in Q4 2019 and held it in 11 quarters. The position peaked at $766K in Q1 2023. 58 funds tracked by Wall St. Rank hold CDLX as of Q1 2026.

  • Walleye Capital reported no remaining Cardlytics position as of Q1 2026 after selling out during the quarter.
  • Walleye Capital sold 1,075 Cardlytics shares in Q1 2026, an estimated $12.4K.
  • Walleye Capital first reported a position in Cardlytics in Q4 2019 and held it in 11 quarters.
  • Walleye Capital's Cardlytics position peaked at $766K in Q1 2023.
  • 58 funds tracked by Wall St. Rank held Cardlytics as of Q1 2026.

Based on Walleye Capital's 13F filing for Q1 2026, filed 11 May 2026.